The primary long-range objective of this application is to elucidate and characterize the actions of endogenous opioid peptides in their role as neurotransmitters in the CNS. If the medical and societal problems related to opiate use and abuse are to be fully appreciated, our understanding of the normal, physiological actions of the endogenous opioid peptide system must be increased. More specifically, this proposal investigates the neurophysiological effects of the dynorphin family of opioid peptides in the hippocampal region of the brain. The relatively well characterized anatomy and physiology of the hippocampus makes it an ideal preparation in which to determine fundamental mechanisms by which endogenous opioid peptides may elicit their effects throughout the nervous system.
The specific aims address basic questions regarding the actions of dynorphin peptides, which are contained within granule cells of the dentate gyrus region in the hippocampal slice preparation: Under what conditions are these peptides released? What is the spatial extent of dynorphin influence on synaptic transmission in the molecular layer of the dentate gyrus? What is the mechanism involved in the release of these neurotransmitters from the dynorphin-containing granule cells? Electrophysiological techniques such as whole-cell voltage-clamp extracellular population responses, and dual intracellular recording methods will be applied in the in vitro hippocampal slice preparation to investigate these questions. It is expected that the information obtained from these studies will add to our understanding of how the nervous system normally utilizes endogenous opioids, and by extension, how it may respond under conditions of tolerance and/or addiction, where chronic opiate exposure has occurred.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29DA011040-04
Application #
6329155
Study Section
Human Development Research Subcommittee (NIDA)
Program Officer
Volman, Susan
Project Start
1998-02-01
Project End
2002-11-30
Budget Start
2001-03-15
Budget End
2001-11-30
Support Year
4
Fiscal Year
2001
Total Cost
$100,787
Indirect Cost
Name
North Dakota State University
Department
Pharmacology
Type
Schools of Pharmacy
DUNS #
City
Fargo
State
ND
Country
United States
Zip Code
58108
Thompson, Angela M; Swant, Jarod; Wagner, John J (2005) Cocaine-induced modulation of long-term potentiation in the CA1 region of rat hippocampus. Neuropharmacology 49:185-94
Thompson, A M; Swant, J; Gosnell, B A et al. (2004) Modulation of long-term potentiation in the rat hippocampus following cocaine self-administration. Neuroscience 127:177-85
Thompson, Angela M; Gosnell, Blake A; Wagner, John J (2002) Enhancement of long-term potentiation in the rat hippocampus following cocaine exposure. Neuropharmacology 42:1039-42
Wagner, J J; Etemad, L R; Thompson, A M (2001) Opioid-mediated facilitation of long-term depression in rat hippocampus. J Pharmacol Exp Ther 296:776-81
Wang, H; Wagner, J J (1999) Priming-induced shift in synaptic plasticity in the rat hippocampus. J Neurophysiol 82:2024-8